William Mack & Associates’s Definium Therapeutics DFTX Stock Holding History
Bought
Maintained
Sold
Other funds holding DFTX
William Mack & Associates's DFTX Position: Q3 2026 in Review
William Mack & Associates opened a new position in Definium Therapeutics (DFTX) in Q3 2026: 66 shares worth $2.51K. The stake represents ﹤0.01% of the portfolio and ranks #517 among its holdings.
354 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.
- William Mack & Associates held 66 shares of Definium Therapeutics worth $2.51K as of Q3 2026.
- Definium Therapeutics was a new William Mack & Associates position in Q3 2026.
- Definium Therapeutics made up ﹤0.01% of William Mack & Associates's portfolio in Q3 2026, its #517 holding.
- 354 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.
Based on William Mack & Associates's 13F filing for Q3 2026, filed 27 Oct 2026.